Science News
from research organizations

Groundbreaking discovery of the cellular origin of cervical cancer

Date:
June 12, 2012
Source:
Agency for Science, Technology and Research (A*STAR), Singapore
Summary:
Scientists have identified a unique set of cells in the cervix that are the cause of human papillomavirus-related cervical cancers. Significantly, the team also showed that these cells do not regenerate when excised. These findings have immense clinical implications in the diagnosis, prevention and treatment of cervical cancer.
Share:
         
Total shares:  
FULL STORY

A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS) together with clinicians from Boston's Brigham and Women's Hospital (BWH) have identified a unique set of cells in the cervix that are the cause of human papillomaviruses (HPV) related cervical cancers. Significantly, the team also showed that these cells do not regenerate when excised. These findings have immense clinical implications in the diagnosis, prevention and treatment of cervical cancer.

The study was published in the Proceedings of the National Academy of Sciences (PNAS), this week.

Cervical cancer is the 7th most common female cancer in Singapore and about 200 cases are diagnosed every year.[1] Infection with HPV is the most common cause or risk factor for cervical cancer. HPV infection causes pre-invasive cancer, termed CIN (Cervical Intraepithelial Neoplasia), which are pre-cancerous lesions that can progress and potentially become invasive cancer if left untreated.

Dr Christopher P. Crum, Director of Women's and Perinatal Pathology in the Department of pathology at BWH, said, "It has been a decades-old mystery why cervical cancers caused by HPV arise only from a discrete region of the cervix, known as the 'squamocolumnar junction', despite the presence of the virus throughout the genital tract. The discovery of these cells finally resolves this mystery and will have wide-ranging impact from developing more meaningful animal models of early cervical carcinogenesis to clinical implications." The team discovered that this discrete set of cells, located at the squamocolumnar junction of the cervix, uniquely express biomarkers that are seen in all forms of invasive cervical cancers linked to HPV. This means that the signature markers of this population of cells can provide a way of distinguishing potentially dangerous precancerous lesions from those with a benign prognosis.

Dr Wa Xian, Principal Investigator at IMB, said, "Our study also revealed that this exotic population of cells does not reappear after ablation[2] by cone biopsy. This finding helps to explain the low rate of new HPV infections in the cervix after excisional therapy and also raises the distinct possibility that preemptive removal of these cells in young women could reduce their risk of cervical cancer. This could be an alternative to current vaccines which only protect against HPV 16 and 18."

This study further validates previous work[3] by Dr Xian and Dr McKeon in collaboration with BWH and NUS, which showed for the first time that some cancers originate from just a small set of cells that are unique from the other cells that reside around them.

Dr Frank Mckeon, Senior Group Leader at GIS, said, "Our previous work on esophageal cancer opened up the possibility of 'preventive therapy' to stamp out the disease by eliminating this small group of cells. This recent work in the cervix further validates this concept and raises important possibilities for early intervention to prevent malignancies linked to very small populations of these unusual, discrete population of cells."

Prof Birgitte Lane, Executive Director of IMB, said, ""This compelling study lends further weight to the importance of specific target cell populations underlying cancer. It is a powerful example of what can be done by combining skilled pathology with modern molecular genetics to uncover important new information, even in such a well-studied disease as cervical cancer."

Notes:

[1]http://www.singhealth.com.sg/PatientCare/ConditionsAndTreatments/Pages/Cervical-Cancer-Cervix-Cancer.aspx

[2] Cervical ablation is the removal of some of the outer layers of the cervix. Gynecologists perform cervical ablation when there is evidence or suspicion of cervical cancer.

[3] This paper can be found in the 24 June, 2011 advance online issue of Cell entitled "Residual Embryonic Cells as Precursors of a Barrett's-Like Metaplasia."


Story Source:

The above story is based on materials provided by Agency for Science, Technology and Research (A*STAR), Singapore. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Herfs, Y. Yamamoto, A. Laury, X. Wang, M. R. Nucci, M. E. McLaughlin-Drubin, K. Munger, S. Feldman, F. D. McKeon, W. Xian, C. P. Crum. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proceedings of the National Academy of Sciences, 2012; DOI: 10.1073/pnas.1202684109

Cite This Page:

Agency for Science, Technology and Research (A*STAR), Singapore. "Groundbreaking discovery of the cellular origin of cervical cancer." ScienceDaily. ScienceDaily, 12 June 2012. <www.sciencedaily.com/releases/2012/06/120612101613.htm>.
Agency for Science, Technology and Research (A*STAR), Singapore. (2012, June 12). Groundbreaking discovery of the cellular origin of cervical cancer. ScienceDaily. Retrieved April 28, 2015 from www.sciencedaily.com/releases/2012/06/120612101613.htm
Agency for Science, Technology and Research (A*STAR), Singapore. "Groundbreaking discovery of the cellular origin of cervical cancer." ScienceDaily. www.sciencedaily.com/releases/2012/06/120612101613.htm (accessed April 28, 2015).

Share This Page:


Health & Medicine News
April 28, 2015

Latest Headlines
updated 12:56 pm ET